Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Discoidin domain-containing receptors (DDRs) are a unique subfamily of receptor tyrosine kinases (RTKs) that function as non-integrin collagen receptors. There are two main members in mammals: DDR1 and DDR2. These receptors play critical roles in cell signaling, development, tissue homeostasis, and disease processes such as fibrosis and cancer. They exhibit slow but sustained kinase activation upon collagen engagement, a unique feature among RTKs. DDRs regulate diverse cellular processes and act as sensors for the extracellular matrix (ECM), translating changes in ECM composition into intracellular signals that influence cell behavior. Altered expression or function of DDRs has been linked to several pathologies, making them promising therapeutic targets.
Modulation of DDR activity or downstream pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Discoidin Domain-containing Receptors (DDRs).